Log in

Brainstorm Cell Therapeutics SEC Filings & 10K Form (NASDAQ:BCLI)

$3.95
+0.05 (+1.28 %)
(As of 10/20/2019 04:00 PM ET)
Today's Range
$3.86
Now: $3.95
$3.95
50-Day Range
$3.70
MA: $3.92
$4.08
52-Week Range
$2.92
Now: $3.95
$4.50
Volume30,480 shs
Average Volume42,516 shs
Market Capitalization$89.07 million
P/E RatioN/A
Dividend YieldN/A
Beta1.21

SEC Filings

Brainstorm Cell Therapeutics (NASDAQ:BCLI) SEC Filings

DateFilerForm TypeView
09/09/2019
7:01 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
7:00 AM
Brainstorm Cell Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
7:00 AM
Brainstorm Cell Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/02/2019
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
08/30/2019
4:02 PM
ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 424B1
08/16/2019
4:17 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/13/2019
5:03 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
4:09 PM
Brainstorm Cell Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
08/02/2019
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 424B3
08/02/2019
8:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
4:03 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:03 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
05/13/2019
7:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/01/2019
2:34 PM
Brainstorm Cell Therapeutics (Filer)
Form 10-K/A
03/12/2019
5:12 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
4:02 PM
Brainstorm Cell Therapeutics (Issuer)
Kern Ralph Dr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:00 AM
Almenoff June Sherie (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:33 PM
Brainstorm Cell Therapeutics (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:32 PM
Brainstorm Cell Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/30/2018
4:05 PM
Brainstorm Cell Therapeutics (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:05 PM
Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:04 PM
ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:03 PM
Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:01 PM
Brainstorm Cell Therapeutics (Issuer)
TAUB MALCOLM S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:00 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
5:06 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2018
7:00 AM
Brainstorm Cell Therapeutics (Filer)
Form DEF 14A
09/28/2018
4:26 PM
Brainstorm Cell Therapeutics (Filer)
Form 424B1
09/21/2018
4:17 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3/A
09/04/2018
4:02 PM
Araya Arturo (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2018
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2018
7:01 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2018
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
06/29/2018
3:07 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/20/2018
5:03 AM
Brainstorm Cell Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
06/08/2018
10:40 AM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2018
7:06 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B3
06/07/2018
7:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
7:01 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/26/2018
3:49 PM
Brainstorm Cell Therapeutics (Issuer)
Kern Ralph Dr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2018
3:45 PM
Araya Arturo (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2018
9:50 AM
Almenoff June Sherie (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4/A
03/20/2018
9:48 AM
Brainstorm Cell Therapeutics (Issuer)
Kern Ralph Dr. (Reporting)
Form 4/A
03/16/2018
5:06 AM
Almenoff June Sherie (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2018
5:07 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2018
3:50 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2018
3:30 PM
Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2018
3:30 PM
Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2018
7:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel